Iovance Biotherapeutics, Inc.

Solid-tumor cell-therapy company commercializing lifileucel and expanding TIL therapy across melanoma, lung and other cancers.

Back to company catalog

Oncology / solid tumors · Autologous tumor-infiltrating lymphocyte (TIL) cell therapy · Commercial + Phase 3

Compare report options